Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Fredric L. Coe

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Nephrology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Chicago, ChicagoBA06/1955Liberal Arts
    University of Chicago, ChicagoBS06/1957Biology
    University of Chicago, ChicagoMD06/1961Medicine
    Michael Reese Hospital, Chicago06/1965Medical Residency
    Univ. Texas SW Medical School, Dallas Texas06/1969Fellowship in Nephrology

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Borofsky M, Handa RK, Evan AP, Williams JC, Bledsoe SB, Coe F, Worcester EM, Lingeman JE. In Vivo Renal Tubule pH in Stone Forming Human Kidneys. J Endourol. 2019 Nov 23. PMID: 31760802.
      View in: PubMed
    2. Ennis JL, Luo D, Asplin JR, Coe FL. A laboratory-based algorithm to predict future kidney function decline in older adults with reduced estimated glomerular filtration rate?. Clin Nephrol. 2019 Sep; 92(3):113-122. PMID: 31319905.
      View in: PubMed
    3. Menezes CJ, Worcester EM, Coe FL, Asplin J, Bergsland KJ, Ko B. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 Jul 01; 317(7):F65-F72. PMID: 31017011.
      View in: PubMed
    4. Boghosian ME, Hammes MS, Cassel KW, Akherat SMJ, Coe F. Restoration of wall shear stress in the cephalic vein during extreme hemodynamics. J Med Eng Technol. 2018 Nov; 42(8):617-627. PMID: 30942634.
      View in: PubMed
    5. Borofsky MS, Williams JC, Dauw CA, Cohen A, Evan AC, Coe FL, Worcester E, Lingeman JE. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 Apr; 33(4):337-342. PMID: 30793930.
      View in: PubMed
    6. Evan AP, Coe FL, Lingeman J, Bledsoe S, Worcester EM. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242. PMID: 30066583.
      View in: PubMed
    7. Bergsland KJ, Coe FL, Parks JH, Asplin JR, Worcester EM. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770. PMID: 29126251.
      View in: PubMed
    8. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629. PMID: 29357436.
      View in: PubMed
    9. Williams JC, Borofsky MS, Bledsoe SB, Evan AP, Coe FL, Worcester EM, Lingeman JE. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192. PMID: 28822796.
      View in: PubMed
    10. Javid Mahmoudzadeh Akherat SM, Cassel K, Boghosian M, Hammes M, Coe F. A Predictive Framework to Elucidate Venous Stenosis: CFD & Shape Optimization. Comput Methods Appl Mech Eng. 2017 Jul 01; 321:46-69. PMID: 28649146.
      View in: PubMed
    11. Cohen AJ, Borofsky MS, Anderson BB, Dauw CA, Gillen DL, Gerber GS, Worcester EM, Coe FL, Lingeman JE. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90. PMID: 27824271.
      View in: PubMed
    12. Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33. PMID: 27452364.
      View in: PubMed
    13. Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec; 29(6):715-734. PMID: 27456839.
      View in: PubMed
    14. Hammes M, Boghosian M, Cassel K, Watson S, Funaki B, Doshi T, Mahmoudzadeh Akherat SM, Hines J, Coe F. Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access. PLoS One. 2016; 11(4):e0152873. PMID: 27074019.
      View in: PubMed
    15. Witzmann FA, Evan AP, Coe FL, Worcester EM, Lingeman JE, Williams JC. Label-free proteomic methodology for the analysis of human kidney stone matrix composition. Proteome Sci. 2016; 14:4. PMID: 26924944.
      View in: PubMed
    16. Ennis J, Gillen D, Rubenstein A, Worcester E, Brecher ME, Asplin J, Coe F. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163. PMID: 26471846.
      View in: PubMed
    17. Borofsky MS, Paonessa JE, Evan AP, Williams JC, Coe FL, Worcester EM, Lingeman JE. A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7. PMID: 26414908.
      View in: PubMed
    18. Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015 Dec; 88(6):1240-1249. PMID: 26376133.
      View in: PubMed
    19. Bhojani N, Paonessa JE, Hameed TA, Worcester EM, Evan AP, Coe FL, Borofsky MS, Lingeman JE. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12. PMID: 25988516.
      View in: PubMed
    20. Ko B, Bergsland K, Gillen DL, Evan AP, Clark DL, Baylock J, Coe FL, Worcester EM. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92. PMID: 25947170.
      View in: PubMed
    21. Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70. PMID: 25736620.
      View in: PubMed
    22. Evan AP, Worcester EM, Williams JC, Sommer AJ, Lingeman JE, Phillips CL, Coe FL. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77. PMID: 25615853.
      View in: PubMed
    23. Evan AP, Coe FL, Connors BA, Handa RK, Lingeman JE, Worcester EM. Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49. PMID: 25656372.
      View in: PubMed
    24. Evan AP, Worcester EM, Coe FL, Williams J, Lingeman JE. Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32. PMID: 25108546.
      View in: PubMed
    25. Williams JC, Lingeman JE, Coe FL, Worcester EM, Evan AP. Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7. PMID: 25096802.
      View in: PubMed
    26. Evan AP, Lingeman JE, Worcester EM, Sommer AJ, Phillips CL, Williams JC, Coe FL. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48. PMID: 24478243.
      View in: PubMed
    27. Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84. PMID: 24089413.
      View in: PubMed
    28. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60. PMID: 23863465.
      View in: PubMed
    29. Bergsland KJ, Worcester EM, Coe FL. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9. PMID: 23720347.
      View in: PubMed
    30. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47. PMID: 23438422.
      View in: PubMed
    31. Ennis J, Worcester E, Coe F. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53. PMID: 22505656.
      View in: PubMed
    32. Bergsland KJ, Coe FL, White MD, Erhard MJ, DeFoor WR, Mahan JD, Schwaderer AL, Asplin JR. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8. PMID: 22358148.
      View in: PubMed
    33. Coe FL, Evan A, Worcester E. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92. PMID: 21825103.
      View in: PubMed
    34. Coe FL. "A sudden lift of wings": Poetry and prose about Alzheimer's disease. Perspect Biol Med. 2011; 54(1):106-14. PMID: 21399388.
      View in: PubMed
    35. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8. PMID: 21123489.
      View in: PubMed
    36. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52. PMID: 21063698.
      View in: PubMed
    37. Miller NL, Humphreys MR, Coe FL, Evan AP, Bledsoe SB, Handa SE, Lingeman JE. Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec; 38(6):421-7. PMID: 21057942.
      View in: PubMed
    38. Coe FL, Asplin JR. Medicine. Stopping the stones. Science. 2010 Oct 15; 330(6002):325-6. PMID: 20947749.
      View in: PubMed
    39. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63. PMID: 20818905.
      View in: PubMed
    40. Coe FL. Stones. A matter of doubt--how best to evaluate stone formers. Nat Rev Urol. 2010 Sep; 7(9):483-5. PMID: 20818325.
      View in: PubMed
    41. Worcester EM, Coe FL. Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9. PMID: 20632168.
      View in: PubMed
    42. Coe FL, Evan AP, Lingeman JE, Worcester EM. Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47. PMID: 20625890.
      View in: PubMed
    43. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Philips CL, Coe FL. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7. PMID: 20428098.
      View in: PubMed
    44. Coe FL, Evan AP, Worcester EM, Lingeman JE. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60. PMID: 20411383.
      View in: PubMed
    45. Kohn OF, Coe FL, Ing TS. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int. 2010 Jan; 14(1):39-46. PMID: 19758296.
      View in: PubMed
    46. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Worcester EM. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8. PMID: 19710630.
      View in: PubMed
    47. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23. PMID: 19640901.
      View in: PubMed
    48. Worcester EM, Coe FL. Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol. 2009 Aug; 20(8):1657-9. PMID: 19578005.
      View in: PubMed
    49. Miller NL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5. PMID: 19549258.
      View in: PubMed
    50. Hammes MS, Boghosian ME, Cassel KW, Funaki B, Coe FL. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2190-4. PMID: 19244227.
      View in: PubMed
    51. Ennis J, Kocherginsky M, Schumm LP, Worcester E, Coe FL, Josephson MA. Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8. PMID: 19169005.
      View in: PubMed
    52. Miller NL, Gillen DL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71. PMID: 19021625.
      View in: PubMed
    53. Parks JH, Coe FL. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46. PMID: 19021617.
      View in: PubMed
    54. Patel BN, Passman CM, Fernandez A, Asplin JR, Coe FL, Kim SC, Lingeman JE, Assimos DG. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009 Jan; 181(1):161-6. PMID: 19013593.
      View in: PubMed
    55. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8. PMID: 18793297.
      View in: PubMed
    56. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94. PMID: 18715937.
      View in: PubMed
    57. Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6. PMID: 18662977.
      View in: PubMed
    58. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008 Jun; 35(2):369-91, vii. PMID: 18486720.
      View in: PubMed
    59. Evan AE, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams JC, Shao Y, Worcester EM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9. PMID: 18449170.
      View in: PubMed
    60. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34. PMID: 18286613.
      View in: PubMed
    61. Evan AP, Lingeman JE, Coe FL, Worcester EM. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9. PMID: 18359392.
      View in: PubMed
    62. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32. PMID: 18359393.
      View in: PubMed
    63. Hammes M, Funaki B, Coe FL. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodial Int. 2008 Jan; 12(1):85-9. PMID: 18271847.
      View in: PubMed
    64. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23. PMID: 17724713.
      View in: PubMed
    65. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11. PMID: 17898697.
      View in: PubMed
    66. Matlaga BR, Miller NL, Terry C, Kim SC, Kuo RL, Coe FL, Evan AP, Lingeman JE. The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40. PMID: 17273836.
      View in: PubMed
    67. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9. PMID: 17222634.
      View in: PubMed
    68. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801. PMID: 17264873.
      View in: PubMed
    69. Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol. 2007 Jan; 177(1):31-8. PMID: 17161996.
      View in: PubMed
    70. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75. PMID: 17210796.
      View in: PubMed
    71. Worcester E, Evan A, Bledsoe S, Lyon M, Chuang M, Orvieto M, Gerber G, Coe F. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9. PMID: 17028259.
      View in: PubMed
    72. Asplin JR, Donahue S, Kinder J, Coe FL. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7. PMID: 16941029.
      View in: PubMed
    73. Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603. PMID: 16813897.
      View in: PubMed
    74. Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90. PMID: 16686727.
      View in: PubMed
    75. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35. PMID: 16710357.
      View in: PubMed
    76. Matlaga BR, Williams JC, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724. PMID: 16600740.
      View in: PubMed
    77. Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6. PMID: 16622176.
      View in: PubMed
    78. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8. PMID: 16614720.
      View in: PubMed
    79. Goldfarb DS, Coe FL, Asplin JR. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7. PMID: 16501494.
      View in: PubMed
    80. Stankus N, Worcester E, Hammes M, Coe FL. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6. PMID: 16326738.
      View in: PubMed
    81. Worcester EM, Chuang M, Laven B, Orvieto M, Coe FL, Evan AP, Gerber GS. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection. Urol Res. 2005 Nov; 33(5):380-2. PMID: 16284881.
      View in: PubMed
    82. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608. PMID: 16200192.
      View in: PubMed
    83. Evan AP, Coe FL, Lingeman JE, Worcester E. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9. PMID: 16078085.
      View in: PubMed
    84. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9. PMID: 16112044.
      View in: PubMed
    85. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54. PMID: 15954903.
      View in: PubMed
    86. O'Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15. PMID: 15815943.
      View in: PubMed
    87. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91. PMID: 15673305.
      View in: PubMed
    88. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90. PMID: 15673317.
      View in: PubMed
    89. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005 Jan; 173(1):117-9; discussion 119. PMID: 15592050.
      View in: PubMed
    90. Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol. 2004 Nov-Dec; 232(1-2):137-43. PMID: 15876428.
      View in: PubMed
    91. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43. PMID: 15472188.
      View in: PubMed
    92. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85. PMID: 15253733.
      View in: PubMed
    93. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4. PMID: 14633137.
      View in: PubMed
    94. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13. PMID: 14633144.
      View in: PubMed
    95. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Bledsoe SB, Kim SC, Munch LC, Coe FL. Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9. PMID: 14634375.
      View in: PubMed
    96. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar; 111(5):607-16. PMID: 12618515.
      View in: PubMed
    97. Asplin JR, Bauer KA, Kinder J, Müller G, Coe BJ, Parks JH, Coe FL. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9. PMID: 12631132.
      View in: PubMed
    98. Coe FL. Editorial: Something new about stones. J Urol. 2003 Feb; 169(2):478-9. PMID: 12544291.
      View in: PubMed
    99. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65. PMID: 12472791.
      View in: PubMed
    100. Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6. PMID: 11992040.
      View in: PubMed
    101. Asplin JR, Parks JH, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9. PMID: 11967033.
      View in: PubMed
    102. Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7. PMID: 11956418.
      View in: PubMed
    103. Coe FL, Parks JH. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4. PMID: 11961392.
      View in: PubMed
    104. Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12. PMID: 11912373.
      View in: PubMed
    105. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87. PMID: 11849452.
      View in: PubMed
    106. Parks JH, Asplin JR, Coe FL. Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60. PMID: 11696706.
      View in: PubMed
    107. Coe FL, Wise H, Parks JH, Asplin JR. Proportional reduction of urine supersaturation during nephrolithiasis treatment. J Urol. 2001 Oct; 166(4):1247-51. PMID: 11547051.
      View in: PubMed
    108. Coe FL, Clark C, Parks JH, Asplin JR. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol. 2001 Aug; 166(2):688-93. PMID: 11458118.
      View in: PubMed
    109. Coe FL, Wise H, Parks JH, Fleury PJ, Asplin JR. Differences in urine volume and supersaturation in 2 physician networks. J Urol. 2001 Aug; 166(2):423-8. PMID: 11458041.
      View in: PubMed
    110. Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5. PMID: 11025687.
      View in: PubMed
    111. Goldfarb DS, Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999 Nov 15; 60(8):2269-76. PMID: 10593318.
      View in: PubMed
    112. Nakagawa Y, Coe FL. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta. 1999 Nov; 289(1-2):57-68. PMID: 10556653.
      View in: PubMed
    113. Shahinfar S, Simpson RL, Carides AD, Thiyagarajan B, Nakagawa Y, Umans JG, Parks JH, Coe FL. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85. PMID: 10571797.
      View in: PubMed
    114. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16. PMID: 10504502.
      View in: PubMed
    115. Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81. PMID: 10081841.
      View in: PubMed
    116. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12. PMID: 9987084.
      View in: PubMed
    117. Goldfarb DS, Coe FL. Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999 Feb; 33(2):398-400; discussion 401-3. PMID: 10023657.
      View in: PubMed
    118. Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34. PMID: 9783920.
      View in: PubMed
    119. Goldfarb DS, Coe FL. Foscarnet crystal deposition and renal failure. Am J Kidney Dis. 1998 Sep; 32(3):519-20. PMID: 9740173.
      View in: PubMed
    120. Pillay SN, Asplin JR, Coe FL. Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol. 1998 08; 275(2):F255-61. PMID: 9691016.
      View in: PubMed
    121. Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5. PMID: 9598467.
      View in: PubMed
    122. Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81. PMID: 9536110.
      View in: PubMed
    123. Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8. PMID: 9474121.
      View in: PubMed
    124. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9. PMID: 9453018.
      View in: PubMed
    125. Asplin JR, Parks JH, Coe FL. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8. PMID: 9407506.
      View in: PubMed
    126. Coe FL, Parks JH, Favus MJ. Diet and calcium: the end of an era? Ann Intern Med. 1997 Apr 01; 126(7):553-5. PMID: 9092322.
      View in: PubMed
    127. Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33. PMID: 9101363.
      View in: PubMed
    128. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900. PMID: 9067927.
      View in: PubMed
    129. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5. PMID: 9067894.
      View in: PubMed
    130. Coe FL. "Felix Randal": a poem about medicine. Pharos Alpha Omega Alpha Honor Med Soc. 1997; 60(2):24-8. PMID: 9197141.
      View in: PubMed
    131. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int. 1996 Nov; 50(5):1706-12. PMID: 8914040.
      View in: PubMed
    132. Parks JH, Coe FL. Pathogenesis and treatment of calcium stones. Semin Nephrol. 1996 Sep; 16(5):398-411. PMID: 8890396.
      View in: PubMed
    133. Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7. PMID: 8724894.
      View in: PubMed
    134. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol. 1996 Apr; 270(4 Pt 2):F604-13. PMID: 8967338.
      View in: PubMed
    135. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13. PMID: 8587230.
      View in: PubMed
    136. Coe FL, Parks JH. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69. PMID: 7873747.
      View in: PubMed
    137. Parks JH, Coe FL. An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int. 1994 Jun; 45(6):1722-30. PMID: 7933820.
      View in: PubMed
    138. Coe FL. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9. PMID: 8037000.
      View in: PubMed
    139. Worcester EM, Fellner SK, Nakagawa Y, Coe FL. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8. PMID: 7969673.
      View in: PubMed
    140. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65. PMID: 8127022.
      View in: PubMed
    141. Coe FL, Nakagawa Y, Asplin J, Parks JH. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994; 20(6):378-84. PMID: 7783700.
      View in: PubMed
    142. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992 Oct 15; 327(16):1141-52. PMID: 1528210.
      View in: PubMed
    143. Nakagawa Y, Sirivongs D, Novy MB, Netzer MF, Michaels E, Vogelzang NJ, Coe FL. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res. 1992 Mar 15; 52(6):1573-9. PMID: 1540966.
      View in: PubMed
    144. Coe FL, Parks JH, Webb DR. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42. PMID: 1593849.
      View in: PubMed
    145. Asplin J, DeGanello S, Nakagawa YN, Coe FL. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991 Nov; 261(5 Pt 2):F824-30. PMID: 1951713.
      View in: PubMed
    146. Coe FL, Nakagawa Y, Parks JH. Inhibitors within the nephron. Am J Kidney Dis. 1991 Apr; 17(4):407-13. PMID: 2008908.
      View in: PubMed
    147. Hess B, Nakagawa Y, Parks JH, Coe FL. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol. 1991 Apr; 260(4 Pt 2):F569-78. PMID: 2012207.
      View in: PubMed
    148. Nakagawa Y, Renz CL, Ahmed M, Coe FL. Isolation of nephrocalcin from kidney tissue of nine vertebrate species. Am J Physiol. 1991 Feb; 260(2 Pt 2):F243-8. PMID: 1996674.
      View in: PubMed
    149. Coe FL, Parks JH. Hereditary aspects of calcium nephrolithiasis. Adv Nephrol Necker Hosp. 1991; 20:31-40. PMID: 2063720.
      View in: PubMed
    150. Coe F, Parks JH. Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990 Oct; 38(4):625-31. PMID: 2232503.
      View in: PubMed
    151. Sirivongs D, Nakagawa Y, Vishny WK, Favus MJ, Coe FL. Evidence that mouse renal proximal tubule cells produce nephrocalcin. Am J Physiol. 1989 Sep; 257(3 Pt 2):F390-8. PMID: 2782421.
      View in: PubMed
    152. Nakagawa Y, Otsuki T, Coe FL. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer. FEBS Lett. 1989 Jul 03; 250(2):187-90. PMID: 2753126.
      View in: PubMed
    153. Hess B, Nakagawa Y, Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol. 1989 Jul; 257(1 Pt 2):F99-106. PMID: 2750929.
      View in: PubMed
    154. Maikranz P, Holley JL, Parks JH, Lindheimer MD, Nakagawa Y, Coe FL. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989 Jul; 36(1):108-13. PMID: 2811052.
      View in: PubMed
    155. Hess B. A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. Urol Res. 1989; 17(3):149-50. PMID: 2749944.
      View in: PubMed
    156. Coe FL, Parks JH. The risks of oral contraceptives and estrogen replacement therapy. Perspect Biol Med. 1989; 33(1):86-106. PMID: 2689999.
      View in: PubMed
    157. Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205. PMID: 3202183.
      View in: PubMed
    158. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6. PMID: 3404813.
      View in: PubMed
    159. Coe FL, Parks JH. Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim. PMID: 3126203.
      View in: PubMed
    160. Maikranz P, Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol. 1987 Dec; 1(4):909-19. PMID: 3330492.
      View in: PubMed
    161. Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53. PMID: 3430961.
      View in: PubMed
    162. Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest. 1987 Jun; 79(6):1782-7. PMID: 3584470.
      View in: PubMed
    163. Maikranz P, Coe FL, Parks J, Lindheimer MD. Nephrolithiasis in pregnancy. Am J Kidney Dis. 1987 Apr; 9(4):354-8. PMID: 3555009.
      View in: PubMed
    164. Worcester EM, Nakagawa Y, Coe FL. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72. PMID: 3306319.
      View in: PubMed
    165. Langman CB, Bushinsky DA, Favus MJ, Coe FL. Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis. Am J Physiol. 1986 Nov; 251(5 Pt 2):F911-8. PMID: 3777187.
      View in: PubMed
    166. Favus MJ, Bushinsky DA, Coe FL. Effects of medium pH on duodenal and ileal calcium active transport in the rat. Am J Physiol. 1986 Nov; 251(5 Pt 1):G695-700. PMID: 3096149.
      View in: PubMed
    167. Edington HD, Hancock S, Coe FL, Sugarbaker PH. Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. Surgery. 1986 Sep; 100(3):494-9. PMID: 3738769.
      View in: PubMed
    168. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90. PMID: 3747347.
      View in: PubMed
    169. Bushinsky DA, Favus MJ, Langman CB, Coe FL. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol. 1986 Jul; 251(1 Pt 2):F17-24. PMID: 3755294.
      View in: PubMed
    170. Coe FL, Favus MJ, Parks JH. Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism? N Engl J Med. 1986 Jun 05; 314(23):1508-9. PMID: 3702965.
      View in: PubMed
    171. Bushinsky DA, Levi-Setti R, Coe FL. Ion microprobe determination of bone surface elements: effects of reduced medium pH. Am J Physiol. 1986 Jun; 250(6 Pt 2):F1090-7. PMID: 3717349.
      View in: PubMed
    172. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96. PMID: 3711339.
      View in: PubMed
    173. Lopez M, Nakagawa Y, Coe FL, Tsai C, Michael AF, Scheinman JI. Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI). Kidney Int. 1986 Apr; 29(4):829-33. PMID: 3520093.
      View in: PubMed
    174. Kristensen CG, Nakagawa Y, Coe FL, Lindheimer MD. Effect of atrial natriuretic factor in rat pregnancy. Am J Physiol. 1986 Apr; 250(4 Pt 2):R589-94. PMID: 2938487.
      View in: PubMed
    175. Coe FL, Parks JH. Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57. PMID: 3081562.
      View in: PubMed
    176. Parks JH, Coe FL. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9. PMID: 3565157.
      View in: PubMed
    177. Bushinsky DA, Riera GS, Favus MJ, Coe FL. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest. 1985 Oct; 76(4):1599-604. PMID: 3840495.
      View in: PubMed
    178. Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62. PMID: 4056037.
      View in: PubMed
    179. Langman CB, Favus MJ, Bushinsky DA, Coe FL. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. J Lab Clin Med. 1985 Sep; 106(3):286-92. PMID: 2993458.
      View in: PubMed
    180. Bushinsky DA, Riera GS, Favus MJ, Coe FL. Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis. Am J Physiol. 1985 Sep; 249(3 Pt 2):F361-5. PMID: 2994493.
      View in: PubMed
    181. Bushinsky DA, Goldring JM, Coe FL. Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am J Physiol. 1985 Jun; 248(6 Pt 2):F785-9. PMID: 3839112.
      View in: PubMed
    182. Moore ES, Langman CB, Favus MJ, Coe FL. Role of fetal 1,25-dihydroxyvitamin D production in intrauterine phosphorus and calcium homeostasis. Pediatr Res. 1985 Jun; 19(6):566-9. PMID: 3839301.
      View in: PubMed
    183. Bushinsky DA, Coe FL. Hyperkalemia during acute ammonium chloride acidosis in man. Nephron. 1985; 40(1):38-40. PMID: 3923378.
      View in: PubMed
    184. Nakagawa Y, Parks JH, Kézdy FJ, Coe FL. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9. PMID: 3842199.
      View in: PubMed
    185. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9. PMID: 4033604.
      View in: PubMed
    186. Bushinsky DA, Favus MJ, Coe FL. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol. 1984 Nov; 247(5 Pt 2):F746-52. PMID: 6548610.
      View in: PubMed
    187. Nakagawa Y, Abram V, Coe FL. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol. 1984 Nov; 247(5 Pt 2):F765-72. PMID: 6496744.
      View in: PubMed
    188. Kathpalia SC, Favus MJ, Coe FL. Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest. 1984 Sep; 74(3):805-11. PMID: 6432849.
      View in: PubMed
    189. Coe F. Treatment of hypercalciuria. N Engl J Med. 1984 Jul 12; 311(2):116-8. PMID: 6547507.
      View in: PubMed
    190. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13. PMID: 6377922.
      View in: PubMed
    191. Bushinsky DA, Favus MJ, Coe FL. Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol. 1984 Feb; 246(2 Pt 2):F140-5. PMID: 6546474.
      View in: PubMed
    192. Moore ES, Langman CB, Favus MJ, Schneider AB, Coe FL. Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5. PMID: 6644429.
      View in: PubMed
    193. Nakagawa Y, Abram V, Kézdy FJ, Kaiser ET, Coe FL. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25; 258(20):12594-600. PMID: 6630201.
      View in: PubMed
    194. Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403. PMID: 6645213.
      View in: PubMed
    195. Bushinsky DA, Krieger NS, Geisser DI, Grossman EB, Coe FL. Effects of pH on bone calcium and proton fluxes in vitro. Am J Physiol. 1983 Aug; 245(2):F204-9. PMID: 6881337.
      View in: PubMed
    196. Coe FL. Reflections on stones. West J Med. 1983 Apr; 138(4):558-60. PMID: 18749347.
      View in: PubMed
    197. Favus MJ, Angeid-Backman E, Breyer MD, Coe FL. Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport. Am J Physiol. 1983 Feb; 244(2):G111-5. PMID: 6687417.
      View in: PubMed
    198. Coe FL, Favus MJ. Idiopathic hypercalciuria. Henry Ford Hosp Med J. 1983; 31(4):229-30. PMID: 6689528.
      View in: PubMed
    199. Langman CB, Favus MJ, Bushinsky DA, Coe FL. Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. Trans Assoc Am Physicians. 1983; 96:225-33. PMID: 6093310.
      View in: PubMed
    200. Bushinsky DA, Favus MJ, Schneider AB, Sen PK, Sherwood LM, Coe FL. Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet. Am J Physiol. 1982 Dec; 243(6):F570-5. PMID: 6293313.
      View in: PubMed
    201. Millman S, Strauss AL, Parks JH, Coe FL. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982 Oct; 22(4):366-70. PMID: 7176335.
      View in: PubMed
    202. Bushinsky DA, Coe FL, Katzenberg C, Szidon JP, Parks JH. Arterial PCO2 in chronic metabolic acidosis. Kidney Int. 1982 Sep; 22(3):311-4. PMID: 6816981.
      View in: PubMed
    203. Favus MJ, Coe FL, Kathpalia SC, Porat A, Sen PK, Sherwood LM. Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat. Am J Physiol. 1982 Jun; 242(6):G575-81. PMID: 6896403.
      View in: PubMed
    204. Parks JH, Coe FL, Strauss AL. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91. PMID: 7070404.
      View in: PubMed
    205. Strauss AL, Coe FL, Parks JH. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7. PMID: 7065787.
      View in: PubMed
    206. Favus MJ, Coe FL, Kathpalia SC, Porat A, Sen PK, Sherwood LM. Effects of chlorothiazide administration and dietary calcium restriction on parathyroid function, vitamin D metabolism and intestinal calcium absorption in the rat. Adv Exp Med Biol. 1982; 151:501-7. PMID: 6897485.
      View in: PubMed
    207. Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982 Jan; 72(1):25-32. PMID: 6277190.
      View in: PubMed
    208. Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24. PMID: 7058820.
      View in: PubMed
    209. Coe FL. Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6. PMID: 7282739.
      View in: PubMed
    210. Favus MJ, Berelowitz M, Coe FL. Effects of somatostatin on intestinal calcium transport in the rat. Am J Physiol. 1981 Sep; 241(3):G215-21. PMID: 6116434.
      View in: PubMed
    211. Coe FL, Parks JH. Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44. PMID: 7268958.
      View in: PubMed
    212. Favus MJ, Kathpalia SC, Coe FL. Kinetic characteristics of calcium absorption and secretion by rat colon. Am J Physiol. 1981 May; 240(5):G350-4. PMID: 6786109.
      View in: PubMed
    213. Nakagawa Y, Margolis HC, Yokoyama S, Kézdy FJ, Kaiser ET, Coe FL. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem. 1981 Apr 25; 256(8):3936-44. PMID: 7217065.
      View in: PubMed
    214. Coe FL. Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45. PMID: 7193640.
      View in: PubMed
    215. Favus MJ, Coe FL. [Vitamin D physiology and its application to disorders of calcium metabolism]. Recenti Prog Med. 1981 Feb; 70(2):119-40. PMID: 7027383.
      View in: PubMed
    216. Parks J, Coe F, Favus M. Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81. PMID: 7436644.
      View in: PubMed
    217. Coe FL, Favus MJ. Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36. PMID: 6905773.
      View in: PubMed
    218. Coe FL, Parks JH, Strauss AL. Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10. PMID: 7392192.
      View in: PubMed
    219. Coe FL, Parks JH. Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1. PMID: 7396320.
      View in: PubMed
    220. Fathizadeh A, Fretzin DF, Favus MJ, Coe FL. Primary hyperparathyroidism and basal cell nevus syndrome. Ann Intern Med. 1980 Jul; 93(1):147. PMID: 7396296.
      View in: PubMed
    221. Coe FL, Strauss AL, Tembe V, Le Dun S. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8. PMID: 7401461.
      View in: PubMed
    222. Sitrin MD, Rosenberg IH, Chawla K, Meredith S, Sellin J, Rabb JM, Coe F, Kirsner JB, Kraft SC. Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May; 78(5 Pt 1):1069-79. PMID: 7380180.
      View in: PubMed
    223. Coe FL. Recurrence of renal stones. Lancet. 1980 Mar 22; 1(8169):651. PMID: 6102651.
      View in: PubMed
    224. Favus MJ, Kathpalia SC, Coe FL, Mond AE. Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport. Am J Physiol. 1980 Feb; 238(2):G75-8. PMID: 7361902.
      View in: PubMed
    225. Coe FL, Favus MJ. Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med. 1980 Jan 24; 302(4):224-5. PMID: 7350463.
      View in: PubMed
    226. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50. PMID: 7424690.
      View in: PubMed
    227. Schwartz JS, Kempa JS, Vasilomanolakis EC, Szidon JP, Coe FL, Jao W. Viomycin-induced electrolyte abnormalities. Respiration. 1980; 40(5):284-92. PMID: 6262892.
      View in: PubMed
    228. Favus MJ, Coe FL. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7. PMID: 6937993.
      View in: PubMed
    229. Favus MJ, Coe FL. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53:265-71. PMID: 6938003.
      View in: PubMed
    230. Coe FL, Favus MJ. Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92. PMID: 7013442.
      View in: PubMed
    231. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40. PMID: 759893.
      View in: PubMed
    232. Weber DV, Coe FL, Parks JH, Dunn MS, Tembe V. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4. PMID: 443649.
      View in: PubMed
    233. Coe FL. An inventory of our therapeutic possessions. Med Clin North Am. 1978 Nov; 62(6):1147-56. PMID: 84097.
      View in: PubMed
    234. Coe FL. Symposium on renal therapeutics. Foreword. Med Clin North Am. 1978 Nov; 62(6):1145. PMID: 368442.
      View in: PubMed
    235. Nakagawa Y, Kaiser ET, Coe FL. Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine. Biochem Biophys Res Commun. 1978 Oct 30; 84(4):1038-44. PMID: 728143.
      View in: PubMed
    236. Coe FL. Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3. PMID: 666467.
      View in: PubMed
    237. Moore ES, Coe FL, McMann BJ, Favus MJ. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10. PMID: 660355.
      View in: PubMed
    238. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26. PMID: 661071.
      View in: PubMed
    239. Coe FL, Parks JH, Lindheimer MD. Nephrolithiasis during pregnancy. N Engl J Med. 1978 Feb 09; 298(6):324-6. PMID: 622090.
      View in: PubMed
    240. Coe FL. Metabolic alkalosis. JAMA. 1977 Nov 21; 238(21):2288-90. PMID: 578849.
      View in: PubMed
    241. Ito H, Coe FL. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol. 1977 Nov; 233(5):F455-63. PMID: 920814.
      View in: PubMed
    242. Blum JE, Coe FL. Metabolic acidosis after sulfur ingestion. N Engl J Med. 1977 Oct 20; 297(16):869-70. PMID: 904661.
      View in: PubMed
    243. Coe FL, Keck J, Norton ER. The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23. PMID: 578220.
      View in: PubMed
    244. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10. PMID: 907239.
      View in: PubMed
    245. Gaeke RF, Kaplan EL, Lindheimer MD, Coe F, Shen KL. Maternal primary hyperparathyroidism of pregnancy. Successful treatment by parathyroidectomy. JAMA. 1977 Aug 08; 238(6):508-9. PMID: 577577.
      View in: PubMed
    246. Coe FL, Norton E, Oparil S, Tatar A, Pullman TN. Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92. PMID: 838839.
      View in: PubMed
    247. Coe FL, Moran E, Kavalich AG. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800. PMID: 1010873.
      View in: PubMed
    248. Lehne C, Coe FL. Compensatory phosphaturia after unilateral nephrectomy in the rat. Am J Physiol. 1976 Nov; 231(5 Pt. 1):1625-9. PMID: 998808.
      View in: PubMed
    249. Coe FL, Firpo JJ. Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9. PMID: 1190933.
      View in: PubMed
    250. Coe FL, Firpo JJ, Hollandsworth DL, Segil L, Canterbury JM, Reiss E. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73. PMID: 1202255.
      View in: PubMed
    251. Coe FL, Lawton RL, Goldstein RB, Tembe V. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975 Sep; 149(4):926-9. PMID: 241080.
      View in: PubMed
    252. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50. PMID: 4610395.
      View in: PubMed
    253. Coe FL. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5. PMID: 4843192.
      View in: PubMed
    254. McCarty DJ, Silcox DC, Coe F, Jacobelli S, Reiss E, Genant H, Ellman M. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14. PMID: 4825605.
      View in: PubMed
    255. Coe FL. The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55. PMID: 4593725.
      View in: PubMed
    256. Coe FL, Raisen L. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31. PMID: 4118468.
      View in: PubMed
    257. Pullman TN, Coe FL. Chronic renal failure. Clin Symp. 1973; 25(1):2-32. PMID: 4354517.
      View in: PubMed
    258. Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42. PMID: 4682379.
      View in: PubMed
    259. Coe FL, Canterbury J, Reiss E. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61. PMID: 5164300.
      View in: PubMed
    260. Coe FL. A diagnostic approach to the patient with renal stones. Med Times. 1970 Oct; 98(10):87-94. PMID: 5506397.
      View in: PubMed
    261. Farquhar JK, Scott WN, Coe FL. Hexose monophosphate shunt activity in compensatory renal hypertrophy. Proc Soc Exp Biol Med. 1968 Dec; 129(3):809-12. PMID: 5725099.
      View in: PubMed
    262. Coe FL, Howe RW, Goetting JA. Mechanism of monomethylhydrazine excretion by the mammalian kidney. J Pharmacol Exp Ther. 1968 Sep; 163(1):216-21. PMID: 5673709.
      View in: PubMed
    263. Coe FL, Korty PR. The effect of hydrazine upon renal excretion of sodium, potassium and water. J Pharmacol Exp Ther. 1968 May; 161(1):183-90. PMID: 5648496.
      View in: PubMed
    264. Coe FL, Korty PR. Protein synthesis during compensatory renal hypertrophy. Am J Physiol. 1967 Dec; 213(6):1585-9. PMID: 6075761.
      View in: PubMed
    265. Coe FL, Korty PR. Mechanism of hydrazine excretion by the mammalian kidney. Am J Physiol. 1967 Feb; 212(2):394-9. PMID: 6018024.
      View in: PubMed
    266. Burke G, Halko A, Coe FL. Dynamic clinical studies with radioisotopes and the scintillation camera. I. Sodium iodohippurate I-131 renography. JAMA. 1966 Jul 04; 197(1):15-24. PMID: 5952531.
      View in: PubMed
    267. Kallen RJ, Zaltzman S, Coe FL, Metcoff J. Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders. Medicine (Baltimore). 1966 Jan; 45(1):1-50. PMID: 5323449.
      View in: PubMed
    Coe's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _